HOME › Top Market Reports › Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] – Global Trends & Competitive Analysis to 2017

Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] – Global Trends & Competitive Analysis to 2017

By: marketsandmarkets.com
Publishing Date: October 2012
Report Code: MD 1310

Neurointerventional radiology or endovascular neurosurgery refers to special minimally invasive procedures to diagnose and treat vascular disorders of the brain and spine. With the help of advanced imaging for guidance, neurointerventionalists or neurosurgeons use microcatheters (tiny tubes) to treat many complex disorders. Normally these disorders are treated either by closing (embolization) or opening (recanalization) the abnormal vessels. The neurointerventional device market encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire).

The neurointerventional devices market encompasses neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire).

The global neurointerventional devices market is estimated to be $1,248.5 million in 2012 and is expected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017. Aneurysm Coiling & Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largest share of the global neurointerventional devices market, followed by support devices cerebral balloon angioplasty & stenting systems and neurothrombectomy devices in 2012.

The major driving factor for these markets involves gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures. Growing GDP and healthcare allocation are making developing countries in Asia and Latin America affordable to adapt novel medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoring the interventional procedure over neurosurgery as it offers limited hospital stays, minimal damage to surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimum surgical trauma and lesser surgical scar.

North America dominates the overall neurointerventional devices market. Asia-Pacific market including India, China and Japan, and Latin America market are expected to grow at a higher pace due to the effect of growing GDP and purchasing capability of healthcare institutions in those countries. Coiling procedure and flow diversion have gained popularity in the Asia-Pacific and Latin American market.

The major players operating in the market are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).

Scope of the Report

This research report categorizes the neurointerventional device market for devices used in neurothrombectomy procedure, cerebral angiography and stenting technique, aneurysm coiling procedure and support devices.

Various neurointerventional devices are categorized into:

Neurothrombectomy procedure - Suction/aspiration device, clot retriever, and snare device
Cerebral angiography and stenting technique - Carotid stent, and embolic protection system
Aneurysm coiling procedure – Platinum coil (Bare & Coated), Liquid embolic agents, and Flow diversion device.
Support devices - Microcatheter and Microguidewire

TABLE OF CONTENTS:

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
      1.5.1 MARKET SIZE
      1.5.2 MARKET SHARE
      1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
      1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
      1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
      3.3.1 DRIVERS
            3.3.1.1 Advancements in technology
            3.3.1.2 Increasing aging & obese population
            3.3.1.3 Increasing number of ischemic & hemorrhagic stroke patients
            3.3.1.4 Growing demand for minimally invasive surgery
      3.3.2 RESTRAINTS
            3.3.2.1 Increasing complexity in clinical trials
            3.3.2.2 Decreasing average selling prices
            3.3.2.3 Hospital budget constraints& alternative treatment facilities
      3.3.3 THREATS & OPPORTUNITIES
3.4 TRENDS
3.5 UPCOMING TECHNOLOGIES
3.6 MARKET SHARE ANALYSIS

4 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY TECHNIQUES
4.1 INTRODUCTION
4.2 NEUROTHROMBECTOMY
4.3 CAROTID ARTERY ANGIOGRAPHY & STENTING
4.4 EMBOLIZATION OF ARTERIOVENOUS MALFORMATION ARTERIOVENOUS FISTULA
4.5 COILING PROCEDURE

5 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCTS
5.1 NEUROTHROMBECTOMY DEVICES
      5.1.1 INTRODUCTION
      5.1.2 SUCTION/ASPIRATION DEVICES
      5.1.3 CLOT RETRIEVER
      5.1.4 SNARE
5.2 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS
      5.2.1 INTRODUCTION
      5.2.2 CAROTID ARTERY STENTS
      5.2.3 EMBOLIC PROTECTION SYSTEMS
            5.2.3.1 Distal filter devices
            5.2.3.2 Balloon occlusion devices
5.3 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION
      5.3.1 INTRODUCTION
      5.3.2 EMBOLIC COIL
            5.3.2.1 Bare Platinum Detachable Coil
            5.3.2.2 Coated Detachable Coil
      5.3.3 LIQUID EMBOLIC AGENTS
      5.3.4 FLOW DIVERSION DEVICE
5.4 SUPPORT DEVICES
      5.4.1 INTRODUCTION
      5.4.2 MICROCATHETER
      5.4.3 MICROGUIDEWIRE

6 GEOGRAPHIC ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.3 EUROPE
6.4 ASIA
6.5 REST OF THE WORLD (ROW)

7 COMPETITIVE LANDSCAPE
7.1 MERGERS & ACQUISITIONS
7.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
7.3 NEW PRODUCT LAUNCH
7.4 APPROVAL
7.5 EXPANSION
7.6 OTHER DEVELOPMENTS

8 COMPANY PROFILES
8.1 ABBOTT LABORATORIES
      8.1.1 OVERVIEW
      8.1.2 FINANCIALS
      8.1.3 PRODUCTS & SERVICES
      8.1.4 STRATEGY
      8.1.5 DEVELOPMENTS
8.2 BAYER AG
      8.2.1 OVERVIEW
      8.2.2 FINANCIAL
      8.2.3 PRODUCTS & SERVICES
      8.2.4 STRATEGY
      8.2.5 DEVELOPMENTS
8.3 COAXIA, INC.
      8.3.1 OVERVIEW
      8.3.2 FINANCIALS
      8.3.3 PRODUCTS & SERVICES
      8.3.4 STRATEGY
      8.3.5 DEVELOPMENTS
8.4 COVIDIEN, PLC
      8.4.1 OVERVIEW
      8.4.2 FINANCIALS
      8.4.3 PRODUCTS & SERVICES
      8.4.4 STRATEGY
      8.4.5 DEVELOPMENTS
8.5 JOHNSON & JOHNSON
      8.5.1 OVERVIEW
      8.5.2 FINANCIALS
      8.5.3 PRODUCTS & SERVICES
      8.5.4 STRATEGY
      8.5.5 DEVELOPMENTS
8.6 MERIT MEDICAL SYSTEMS, INC.
      8.6.1 OVERVIEW
      8.6.2 FINANCIALS
      8.6.3 PRODUCTS & SERVICES
      8.6.4 STRATEGY
      8.6.5 DEVELOPMENTS
8.7 NEUROINTERVENTIONAL THERAPEUTICS, INC. (NIT)
      8.7.1 OVERVIEW
      8.7.2 FINANCIALS
      8.7.3 PRODUCTS & SERVICES
      8.7.4 STRATEGY
      8.7.5 DEVELOPMENTS
8.8 NFOCUS NEUROMEDICAL, INC.
      8.8.1 OVERVIEW
      8.8.2 FINANCIALS
      8.8.3 PRODUCTS & SERVICES
      8.8.4 STRATEGY
      8.8.5 DEVELOPMENTS
8.9 PENUMBRA, INC.
      8.9.1 OVERVIEW
      8.9.2 FINANCIALS
      8.9.3 PRODUCTS & SERVICES
      8.9.4 STRATEGY
      8.9.5 DEVELOPMENTS
8.10 REVERSE MEDICAL CORPORATION
       8.10.1 OVERVIEW
       8.10.2 FINANCIALS
       8.10.3 PRODUCTS & SERVICES
       8.10.4 STRATEGY
       8.10.5 DEVELOPMENTS
8.11 STRYKER CORPORATION
       8.11.1 OVERVIEW
       8.11.2 FINANCIALS
       8.11.3 PRODUCTS & SERVICES
       8.11.4 STRATEGY
       8.11.5 DEVELOPMENTS
8.12 TERUMO CORPORATION
       8.12.1 OVERVIEW
       8.12.2 FINANCIALS
       8.12.3 PRODUCTS & SERVICES
       8.12.4 STRATEGY
       8.12.5 DEVELOPMENTS
8.13 VALOR MEDICAL, INC.
       8.13.1 OVERVIEW
       8.13.2 FINANCIALS
       8.13.3 PRODUCTS & SERVICES
       8.13.4 STRATEGY
       8.13.5 DEVELOPMENTS
8.14 W.L.GORE & ASSOCIATES, INC.
       8.14.1 OVERVIEW
       8.14.2 FINANCIALS
       8.14.3 PRODUCTS & SERVICES
       8.14.4 STRATEGY
       8.14.5 DEVELOPMENTS

LIST OF TABLES

TABLE 1 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 2 UPCOMING TECHNOLOGY: PHASE IV CLINICAL TRIAL STUDY
TABLE 3 UPCOMING TECHNOLOGY: PHASE III CLINICAL TRIAL STUDY
TABLE 4 UPCOMING TECHNOLOGY: PHASE II CLINICAL TRIAL STUDY
TABLE 5 UPCOMING TECHNOLOGY: PHASE I CLINICAL TRIAL STUDY
TABLE 6 UPCOMING TECHNOLOGY: 510 (K) APPROVAL
TABLE 7 UPCOMING TECHNOLOGY: OTHERS CLINICAL TRIAL STUDY
TABLE 8 NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 9 GLOBAL NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 10 NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 11 GLOBAL CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 12 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 13 GLOBAL ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 14 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 15 SUCTION/ASPIRATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 16 SUCTION/ASPIRATION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 17 CLOT RETRIEVER MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 18 CLOT RETRIEVER MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 19 SNARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 20 SNARE DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 21 CAROTID ARTERY STENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 22 CAROTID ARTERY STENTS MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 23 EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 24 EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 25 DISTAL FILTER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 26 DISTAL FILTER DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 27 BALLOON OCCLUSION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 28 BALLOON OCCLUSION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 29 GLOBAL EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 30 EMBOLIC COIL MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 31 EMBOLIC COIL MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 32 BARE PLATINUM DETACHABLE COIL MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 33 BARE PLATINUM DETACHABLE COIL MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 34 COATED DETACHABLE COIL MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 35 COATED DETACHABLE COIL MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 36 LIQUID EMBOLIC AGENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 37 LIQUID EMBOLIC AGENTS MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 38 FLOW DIVERSION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 39 FLOW DIVERSION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 40 GLOBAL SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 41 SUPPORT DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 42 MICROCATHETERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 43 MICROCATHETERS MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 44 MICROGUIDEWIRES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 45 MICROGUIDEWIRES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 46 NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 47 NORTH AMERICA: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 48 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 49 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 50 NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 51 NORTH AMERICA: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 52 NORTH AMERICA: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 53 NORTH AMERICA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 54 NORTH AMERICA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 55 NORTH AMERICA: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 56 NORTH AMERICA: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 57 NORTH AMERICA: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 58 NORTH AMERICA: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 59 EUROPE: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 60 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 61 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 62 EUROPE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 63 EUROPE: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 64 EUROPE: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 65 EUROPE: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 66 EUROPE: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 67 EUROPE: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 68 EUROPE: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 69 EUROPE: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 70 EUROPE: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 71 ASIA: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 72 ASIA: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 73 ASIA: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 74 ASIA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 75 ASIA: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 76 ASIA: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 77 ASIA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 78 ASIA: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 79 ASIA: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 80 ASIA: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 81 ASIA: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 82 ASIA: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 83 ROW: NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 84 ROW: NEUROTHROMBECTOMY DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 85 ROW: NEUROTHROMBECTOMY DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 86 ROW: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 87 ROW: EMBOLIC PROTECTION SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 88 ROW: EMBOLIC PROTECTION SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 89 ROW: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 90 ROW: ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 91 ROW: EMBOLIC COIL MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 92 ROW: EMBOLIC COIL MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 93 ROW: SUPPORT DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 94 ROW: SUPPORT DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 95 MERGERS & ACQUISITIONS, 2009 – 2012
TABLE 96 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, 2009 – 2012
TABLE 97 NEW PRODUCT LAUNCH, 2009 – 2012
TABLE 98 APPROVAL, 2009 – 2012
TABLE 99 EXPANSION, 2009 – 2012
TABLE 100 OTHER DEVELOPMENTS, 2009 – 2012
TABLE 101 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 102 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 103 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 104 BAYER AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 105 BAYER AG: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 106 BAYER AG: HEALTHCARE TOTAL REVENUE, BY DIVISIONS, 2009 – 2011 ($MILLION)
TABLE 107 BAYER AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 108 BAYER AG: TOTAL REVENUE OF HEALTHCARE DIVISION, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 109 COVIDIEN, PLC : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 110 COVIDIEN, PLC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 111 COVIDIEN, PLC: MEDICAL DEVICES TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 112 COVIDIEN, PLC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 113 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 114 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 115 JOHNSON AND JOHNSON: MEDICAL DEVICES AND DIAGNOSTICS REVENUE, BY DIVISIONS, 2009 – 2011 ($MILLION)
TABLE 116 JOHNSON AND JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 117 MERIT MEDICAL SYSTEMS, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 118 MERIT MEDICAL SYSTEMS, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 201 ($MILLION)
TABLE 119 MERIT MEDICAL SYSTEMS, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 120 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 121 STRYKER CORPORATION: TOTAL REVENUES, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 122 STRYKER CORPORATION: NEUROTECHNOLOGY AND SPINE SEGMENT TOTAL REVENUE, 2009 – 2011 ($MILLION)
TABLE 123 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 124 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 125 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 126 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET REVENUE, 2012 & 2017
FIGURE 2 NEUROINTERVENTIONAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2012
FIGURE 3 NEUROINTERVENTIONAL DEVICES MARKET SEGMENTATION
FIGURE 4 MARKET DYNAMICS
FIGURE 5 GLOBAL NEUROINTERVENTIONAL MARKET SHARE, BY PLAYERS, 2012
FIGURE 6 NEUROTHROMBECTOMY DEVICES SEGMENTATION
FIGURE 7 NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY PRODUCT SEGMENTS, 2012 & 2017
FIGURE 8 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS SEGMENTATION
FIGURE 9 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION DEVICES SEGMENTATION
FIGURE 10 ANEURYSM COILING & ARTERIOVENOUS MALFORMATION EMBOLIZATION & FISTULA EMBOLIZATION DEVICES MARKET SHARE, BY PRODUCT SEGMENTS, 2012 & 2017
FIGURE 11 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET SHARE, BY GROWTH STRATEGIES, 2009 – 2012

The global neurointerventional devices market is estimated to be $1,248.5 million in 2012 and is expected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017. Aneurysm Coiling & Arteriovenous Malformation Embolization & Fistula embolization segment accounts for the largest share of the global neurointerventional devices market, followed by support devices, cerebral balloon angioplasty & stenting systems and Neurothrombectomy devices in 2012.

Gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures are the major drivers that are slated to propel this market. Growing GDP and healthcare allocation are making developing countries in Asia and Latin America affordable to adapt novel medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoring the interventional procedure over neurosurgery as it offers limited hospital stays, minimal damage to surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimum surgical trauma and lesser surgical scar.

North America commands for the largest share of the global neurointerventional devices market in 2012. Asia-Pacific market including India, China and Japan, and Latin America market are expected to grow at a higher pace due to the effect of growing GDP and purchasing capability of healthcare institutions in those countries.

The major players operating in the market are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).

Global Neurointerventional Devices Market Share Analysis, By Key Players, 2012

Neurointerventional Devices Market, Interventional Neurology Market